Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17752ExperimentalProtein Based Therapies
Tuvirumab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on HBsAg
- Also known as
- Immunoglobulin g 1 (human monoclonal pe1-1 anti-hepatitis b virus surface antigen), disulfide with human monoclonal pe1-1 .lambda.-chain, dimer · Immunoglobulin g 1 (human monoclonal pe1-1 anti-hepatitis b virus surface antigen), disulfide with human monoclonal pe1-1 l-chain, dimer · Immunoglobulin g1, anti-(hepatitis b virus surface antigen) (human monoclonal pe1-1 .gamma.1-chain), disulfide with human monoclonal pe1-1 .lambda.-chain, dimer · Ostavir
- Code names
- OST-577 · PE 1-1 · SDZ-OST 577
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Tuvirumab, and which of those have an active Phase 3 trial?